The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-ResistanceUdayan Chatterji, Philippe Gallay, Kelly A. Wong et al.|Antimicrobial Agents and Chemotherapy|2014Cited by 37
P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTSMichael Bobardt, B. Li, James Baugh et al.|Journal of Hepatology|2014Cited by 0